NDC 17856-0353-2 - Pharbetol Regular strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0353
- Requested NDC
- 17856-0353-2
- Package NDCs from labels
- 17856-0353-2, 17856-0353-1, 17856-0353-4, 17856-0353-3
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-06-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PHARBEST IBUPROFEN Drug Facts | ATLANTIC BIOLOGICALS CORP. | 2025-06-05 | HUMAN OTC DRUG LABEL |
| Pharbetol Regular strength - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2024-04-30 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0353-1 | 2024-06-26 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
| 17856-0353-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0353-1 | PharbetolRegular strength | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 3 | |
| 17856-0353-2 | PharbetolRegular strength | 1 in 1 POUCH | TABLET | 1 | 3 | |
| 17856-0353-4 | PharbetolRegular strength | 24 in 1 BOTTLE | TABLET | 24 | 3 | |
| 17856-0353-3 | PharbetolRegular strength | 28 in 1 BOTTLE | TABLET | 28 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, Legacy NDC, 3 package rows | 20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip |
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | AvPAK | e5fbd6b8-85e7-8847-e053-2a95a90a52ed | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Aspirin Low Dose | ASPIRIN | A-S Medication Solutions | 3294ba24-f198-485e-88fc-435964434b80 | 2025-01-09 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Major Pharmaceuticals | 32ea1230-f9ae-46b0-910e-05cd187cee34 | 2025-01-09 | Warnings | M013 362O9ITL9D |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | ACETAMINOPHEN AND CODEINE PHOSPHATE | Aphena Pharma Solutions - Tennessee, LLC | d53bf9b7-1652-4287-a0c1-e89f6f0cb7f1 | 2025-01-08 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| APADAZ | BENZHYDROCODONE AND ACETAMINOPHEN | Zevra Therapeutics, Inc. | 0590d4e5-7107-4015-a6a8-deac14265aa2 | 2025-01-07 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Nighttime Cold and Flu | ACETAMINOPHEN, DOXYLAMINE SUCCINATE, DEXTROMETHORPHAN HBR | Health Pharma USA LLC | 29bb7822-76c6-e39d-e063-6294a90a64fb | 2025-01-07 | Warnings | 362O9ITL9D |
| GeriCare Liquid Pain Relief | ACETAMINOPHEN | Geri-Care Pharmaceuticals, Corp | 85a074da-14b7-4db5-9d47-8ad19f520721 | 2025-01-06 | Warnings | M013 362O9ITL9D |
| gas relief | SIMETHICONE | Strategic Sourcing Services LLC | 23005295-c5f2-4a76-8431-4a9b8d817d4d | 2025-01-03 | Warnings | M |
| PUBLIX SUPER MARKETS INC | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | PUBLIX SUPER MARKETS INC | 08a46808-2bb2-0b40-e063-6394a90af80e | 2025-01-02 | Warnings | 362O9ITL9D |
| Butalbital, Acetaminophen, and Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | NuCare Pharmaceuticals, Inc. | 4ecb7bdc-4a43-7444-e054-00144ff88e88 | 2025-01-02 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Multi-Symptom Nighttime Cold and Flu Relief | ACETAMINOPHEN, DOXYLAMINE SUCCINATE, DEXTROMETHORPHAN HBR | Advanced Rx LLC | a75553bd-f3f0-47bd-b3c3-aeeb0d1a81b4 | 2025-01-01 | Warnings | 362O9ITL9D |
| Acetaminophen and Codeine Phosphate | ACETAMINOPHEN AND CODEINE PHOSPHATE | Proficient Rx LP | 5d9123f6-b322-4fa0-bf48-6335a6adcbb8 | 2025-01-01 | Warnings, Adverse reactions | 362O9ITL9D |
| Headache, Circle K | ACETAMINOPHEN, CAFFEINE, ASPIRIN TABLET | Lil' Drug Store Products, Inc. | e711ff0a-2fa0-1f2a-e053-2a95a90a4e38 | 2024-12-31 | Warnings | M013 362O9ITL9D |
| Extra Strength Headache, Lil Drug Store | EXTRA STRENGHT HEADACHE RELIEF- ACETAMINOPHEN, ASPIRIN, CAFFEINE TABLET | Lil' Drug Store Products, Inc. | 0c41deda-490b-f5d2-e063-6394a90a5047 | 2024-12-31 | Warnings | M013 362O9ITL9D |
| Extra Strength Headache, Circle K | ACETAMINOPHEN/ASPIRIN/CAFFEINE TABLET | Lil' Drug Store Products, Inc. | d18e1631-de43-4b29-e053-2995a90af56d | 2024-12-31 | Warnings | M013 362O9ITL9D |
| Pain Reliever | ACETAMINOPHEN 500 MG, FILM-COATED TABLET | Lil' Drug Store Products, Inc. | e5f9def4-4cf5-4e06-e053-2995a90a07ea | 2024-12-31 | Warnings | M013 362O9ITL9D |
| Regular Strength Pain Relief | ACETAMINOPHEN | Geri-Care Pharmaceutical Corp | 6158e954-32d8-4718-e053-2a91aa0a27f3 | 2024-12-31 | Warnings | M013 313782 362O9ITL9D |
| Acetaminophen | EXTRA STRENGTH PAIN RELIEF | NuCare Pharmaceuticals,Inc. | a32f346e-71d0-cc11-e053-2a95a90ae88c | 2024-12-31 | Warnings | 362O9ITL9D |
| Butalbital/Acetaminophen/Caffeine | BUTALBITAL/ACETAMINOPHEN/CAFFEINE | Advanced Rx Pharmacy of Tennessee, LLC | f16429e2-4944-5bbc-e053-2a95a90ab528 | 2024-12-31 | Warnings, Adverse reactions | 362O9ITL9D |
| Aspirin | ASPIRIN | Advanced Rx Pharmacy of Tennessee, LLC | f8375029-e567-c6a5-e053-6394a90a5b67 | 2024-12-31 | Warnings | M013 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.